TY - JOUR AU - Allemani, C. AU - Matsuda, T. AU - Carlo, V. PY - 2018 DA - 2018// TI - Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries JO - Lancet VL - 391 UR - https://doi.org/10.1016/S0140-6736(17)33326-3 DO - 10.1016/S0140-6736(17)33326-3 ID - Allemani2018 ER - TY - JOUR AU - Bray, F. AU - Ferlay, J. AU - Soerjomataram, I. AU - Siegel, R. L. AU - Torre, L. A. AU - Jemal, A. PY - 2018 DA - 2018// TI - Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries JO - CA Cancer J Clin VL - 68 UR - https://doi.org/10.3322/caac.21492 DO - 10.3322/caac.21492 ID - Bray2018 ER - TY - STD TI - https://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf. NCCN Guidelines Version 5.2017:Epithelial Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer & Less Common Histopathologies (February 2, 2018). UR - https://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf ID - ref3 ER - TY - JOUR AU - Ozols, R. F. PY - 2003 DA - 2003// TI - Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a gynecologic oncology group study JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.02.153 DO - 10.1200/JCO.2003.02.153 ID - Ozols2003 ER - TY - JOUR AU - Deng, J. AU - Bai, X. AU - Feng, X. AU - Ni, J. AU - Beretov, J. AU - Graham, P. AU - Li, Y. PY - 2019 DA - 2019// TI - Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression JO - BMC Cancer VL - 19 UR - https://doi.org/10.1186/s12885-019-5824-9 DO - 10.1186/s12885-019-5824-9 ID - Deng2019 ER - TY - JOUR AU - Gasparri, M. L. PY - 2018 DA - 2018// TI - MiRNAs and their interplay with PI3K/AKT/mTOR pathway in ovarian cancer cells: a potential role in platinum resistance JO - J Cancer Res Clin Oncol VL - 144 UR - https://doi.org/10.1007/s00432-018-2737-y DO - 10.1007/s00432-018-2737-y ID - Gasparri2018 ER - TY - JOUR AU - Gasparri, M. L. AU - Bardhi, E. AU - Ruscito, I. AU - Papadia, A. AU - Farooqi, A. A. AU - Marchetti, C. AU - Bogani, G. AU - Ceccacci, I. AU - Mueller, M. D. AU - Benedetti Panici, P. PY - 2017 DA - 2017// TI - PI3K/AKT/mTOR pathway in ovarian Cancer treatment: are we on the right track JO - Geburtshilfe Frauenheilkd VL - 77 UR - https://doi.org/10.1055/s-0043-118907 DO - 10.1055/s-0043-118907 ID - Gasparri2017 ER - TY - JOUR AU - Li, P. P. AU - Feng, L. L. AU - Chen, N. AU - Ge, X. L. AU - Lv, X. AU - Lu, K. AU - Ding, M. AU - Yuan, D. AU - Wang, X. PY - 2015 DA - 2015// TI - Metadherin contributes to the pathogenesis of chronic lymphocytic leukemia partially through Wnt/β-catenin pathway JO - Med Oncol VL - 32 ID - Li2015 ER - TY - JOUR AU - Pei, G. AU - Luo, M. AU - Ni, X. AU - Wu, J. AU - Wang, S. AU - Ma, Y. AU - Yu, J. PY - 2018 DA - 2018// TI - Autophagy facilitates Metadherin-induced chemotherapy resistance through the AMPK/ATG5 pathway in gastric Cancer JO - Cell Physiol Biochem VL - 46 UR - https://doi.org/10.1159/000488742 DO - 10.1159/000488742 ID - Pei2018 ER - TY - STD TI - Sarkar D, Fisher PB. AEG-1/MTDH/LYRIC: clinical significance. Adv Cancer Res. 2013;120:39–74. https://www.ncbi.nlm.nih.gov/pubmed/23889987 UR - https://www.ncbi.nlm.nih.gov/pubmed/23889987 ID - ref10 ER - TY - JOUR AU - Yang, L. AU - Tian, Y. AU - Leong, W. S. AU - Song, H. AU - Yang, W. AU - Wang, M. AU - Wang, X. AU - Kong, J. AU - Shan, B. AU - Song, Z. PY - 2018 DA - 2018// TI - Efficient and tumor-specific knockdown of MTDH gene attenuates paclitaxel resistance of breast cancer cells both in vivo and in vitro JO - Breast Cancer Res VL - 20 UR - https://doi.org/10.1186/s13058-018-1042-7 DO - 10.1186/s13058-018-1042-7 ID - Yang2018 ER - TY - JOUR AU - Zhu, G. C. PY - 2015 DA - 2015// TI - Metadherin regulation of vascular endothelial growth factor expression is dependent upon the PI3K/Akt pathway in squamous cell carcinoma of the head and neck JO - Med (Baltimore) VL - 94 UR - https://doi.org/10.1097/MD.0000000000000502 DO - 10.1097/MD.0000000000000502 ID - Zhu2015 ER - TY - JOUR AU - Li, C. PY - 2012 DA - 2012// TI - Elevated expression of astrocyte elevated gene-1 (AEG-1) is correlated with cisplatin-based chemoresistance and shortened outcome in patients with stages III-IV serous ovarian carcinoma JO - Histopathol VL - 60 UR - https://doi.org/10.1111/j.1365-2559.2012.04182.x DO - 10.1111/j.1365-2559.2012.04182.x ID - Li2012 ER - TY - JOUR AU - Jamaspishvili, T. AU - Berman, D. M. AU - Ross, A. E. AU - Scher, H. I. AU - Marzo, A. M. AU - Squire, J. A. AU - Lotan, T. L. PY - 2018 DA - 2018// TI - Clinical implications of PTEN loss in prostate cancer JO - Nat Rev Urol VL - 15 UR - https://doi.org/10.1038/nrurol.2018.9 DO - 10.1038/nrurol.2018.9 ID - Jamaspishvili2018 ER - TY - JOUR AU - Liao, Y. AU - Shen, L. AU - Zhao, H. AU - Liu, Q. AU - Fu, J. AU - Guo, Y. AU - Peng, R. AU - Cheng, L. PY - 2017 DA - 2017// TI - LncRNA CASC2 interacts with miR-181a to modulate Glioma growth and resistance to TMZ through PTEN pathway JO - J Cell Biochem VL - 118 UR - https://doi.org/10.1002/jcb.25910 DO - 10.1002/jcb.25910 ID - Liao2017 ER - TY - JOUR AU - Liu, Y. AU - Yang, E. J. AU - Zhang, B. AU - Miao, Z. AU - Wu, C. AU - Lyu, J. AU - Tan, K. AU - Poon, T. AU - Shim, J. S. PY - 2018 DA - 2018// TI - PTEN deficiency confers colorectal cancer cell resistance to dual inhibitors of FLT3 and aurora kinase a JO - Cancer Lett VL - 436 UR - https://doi.org/10.1016/j.canlet.2018.08.011 DO - 10.1016/j.canlet.2018.08.011 ID - Liu2018 ER - TY - JOUR AU - Shen, H. PY - 2014 DA - 2014// TI - Alteration in Mir-21/PTEN expression modulates gefitinib resistance in non-small cell lung cancer JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0103305 DO - 10.1371/journal.pone.0103305 ID - Shen2014 ER - TY - JOUR AU - Wang, L. AU - Wang, C. AU - Jin, S. AU - Qu, D. AU - Ying, H. PY - 2015 DA - 2015// TI - Expression of NF-κB and PTEN in primary epithelial ovarian carcinoma and the correlation with chemoresistance JO - Int J Clin Exp Pathol VL - 8 ID - Wang2015 ER - TY - JOUR AU - Ying, H. AU - Qu, D. AU - Liu, C. AU - Ying, T. AU - Lv, J. AU - Jin, S. AU - Xu, H. PY - 2015 DA - 2015// TI - Chemoresistance is associated with Beclin-1 and PTEN expression in epithelial ovarian cancers JO - Oncol Lett VL - 9 UR - https://doi.org/10.3892/ol.2015.2950 DO - 10.3892/ol.2015.2950 ID - Ying2015 ER - TY - JOUR AU - Laraia, L. AU - McKenzie, G. AU - Spring, D. R. AU - Venkitaraman, A. R. AU - Huggins, D. J. PY - 2015 DA - 2015// TI - Overcoming chemical, biological, and computational challenges in the development of inhibitors targeting protein-protein interactions JO - Chem Biol VL - 22 UR - https://doi.org/10.1016/j.chembiol.2015.04.019 DO - 10.1016/j.chembiol.2015.04.019 ID - Laraia2015 ER - TY - JOUR AU - Liang, Y. PY - 2015 DA - 2015// TI - Epigenetic activation of TWIST1 by MTDH promotes Cancer stem-like cell traits in breast Cancer JO - Cancer Res VL - 75 UR - https://doi.org/10.1158/0008-5472.CAN-15-0930 DO - 10.1158/0008-5472.CAN-15-0930 ID - Liang2015 ER - TY - JOUR AU - Haslehurst, A. M. PY - 2012 DA - 2012// TI - EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer JO - BMC Cancer VL - 12 UR - https://doi.org/10.1186/1471-2407-12-91 DO - 10.1186/1471-2407-12-91 ID - Haslehurst2012 ER - TY - JOUR AU - Lee, M. Y. AU - Seo, C. S. AU - Ha, H. AU - Park, E. AU - Kim, J. Y. AU - Shin, H. K. PY - 2018 DA - 2018// TI - The genotoxicity of an aqueous extract of Gyejibokryeong-hwan JO - BMC Complement Altern Med VL - 18 UR - https://doi.org/10.1186/s12906-017-2054-z DO - 10.1186/s12906-017-2054-z ID - Lee2018 ER - TY - JOUR AU - Zhang, L. S. AU - Yang, F. W. AU - Zhang, J. H. AU - Zheng, W. K. AU - Zhang, M. Y. AU - Li, Y. AU - Zhao, H. J. PY - 2017 DA - 2017// TI - Guizhi Fuling capsule / pill treatment for chronic pelvic inflammatory disease:a systematic review of randomized clinical trials JO - Zhongguo Zhong Yao Za Zhi VL - 42 ID - Zhang2017 ER - TY - JOUR AU - Jin, S. E. AU - Seo, C. S. AU - Lee, M. Y. AU - Shin, H. K. AU - Yang, M. J. AU - Ha, H. PY - 2018 DA - 2018// TI - Sub-chronic toxicity of Gyejibokryeong-hwan in Sprague-Dawley rats JO - J Ethnopharmacol VL - 224 UR - https://doi.org/10.1016/j.jep.2018.06.017 DO - 10.1016/j.jep.2018.06.017 ID - Jin2018 ER - TY - JOUR AU - Kim, J. E. AU - Cho, J. AU - Kwon, O. AU - Kim, A. R. AU - Park, H. J. AU - Jung, S. Y. AU - Kim, J. H. AU - Kim, M. AU - Lee, H. Y. AU - Lee, J. H. PY - 2017 DA - 2017// TI - Effect of Guizhifulingwan (Keishibukuryogan) on climacteric syndrome: study protocol for a randomized controlled pilot trial JO - Trials VL - 18 UR - https://doi.org/10.1186/s13063-017-1877-8 DO - 10.1186/s13063-017-1877-8 ID - Kim2017 ER - TY - JOUR AU - Tomita, T. AU - Hirayama, A. AU - Matsui, H. AU - Aoyagi, K. PY - 2017 DA - 2017// TI - Effect of Keishibukuryogan, a Japanese traditional Kampo prescription, on improvement of microcirculation and Oketsu and induction of endothelial nitric oxide: a live imaging study JO - Evid Based Complement Alternat Med VL - 2017 ID - Tomita2017 ER - TY - JOUR AU - Jeong, S. J. AU - Lim, H. S. AU - Seo, C. S. AU - Jin, S. E. AU - Yoo, S. R. AU - Lee, N. AU - Shin, H. K. PY - 2015 DA - 2015// TI - Anti-inflammatory actions of herbal formula Gyejibokryeong-hwan regulated by inhibiting chemokine production and STAT1 activation in HaCaT cells JO - Biol Pharm Bull VL - 38 UR - https://doi.org/10.1248/bpb.b14-00660 DO - 10.1248/bpb.b14-00660 ID - Jeong2015 ER - TY - JOUR AU - Hu, C. AU - Wang, Z. AU - Pang, Z. AU - Lu, W. AU - Cai, X. AU - Yang, J. AU - Wang, D. AU - Cao, P. PY - 2014 DA - 2014// TI - Guizhi fuling capsule, an ancient Chinese formula, attenuates endometriosis in rats via induction of apoptosis JO - Climacteric VL - 17 UR - https://doi.org/10.3109/13697137.2013.876618 DO - 10.3109/13697137.2013.876618 ID - Hu2014 ER - TY - JOUR AU - Wu, K. J. AU - Chen, Y. F. AU - Tsai, H. Y. AU - Wu, C. R. AU - Wood, W. G. PY - 2012 DA - 2012// TI - Guizhi-Fuling-wan, a traditional Chinese herbal medicine, ameliorates memory deficits and neuronal apoptosis in the Streptozotocin-induced hyperglycemic rodents via the decrease of Bax/Bcl2 ratio and Caspase-3 expression JO - Evid Based Complement Alternat Med VL - 2012 ID - Wu2012 ER - TY - JOUR AU - Nagata, Y. AU - Goto, H. AU - Hikiami, H. AU - Nogami, T. AU - Fujimoto, M. AU - Shibahara, N. AU - Shimada, Y. PY - 2012 DA - 2012// TI - Effect of keishibukuryogan on endothelial function in patients with at least one component of the diagnostic criteria for metabolic syndrome: a controlled clinical trial with crossover design JO - Evid Based Complement Alternat Med VL - 2012 ID - Nagata2012 ER - TY - JOUR AU - Lu, C. C. PY - 2016 DA - 2016// TI - Guizhi Fuling wan as a novel agent for Intravesical treatment for bladder Cancer in a mouse model JO - Mol Med VL - 22 UR - https://doi.org/10.2119/molmed.2015.00085 DO - 10.2119/molmed.2015.00085 ID - Lu2016 ER - TY - JOUR AU - Shihong, J. AU - Lan, L. AU - Yaosong, W. AU - Leida, X. AU - Peixun, Z. PY - 2018 DA - 2018// TI - mechanism of Guizhi Fuling wan in inhibiting proliferation of human breast Cancer MCF-7 cells JO - Chin J Exp Tradit Med Formulae VL - 24 ID - Shihong2018 ER - TY - JOUR AU - Chiwen, H. AU - Xiaoqi, L. PY - 2019 DA - 2019// TI - Guizhi Fuling pill in the treatment of cervical carcinoma of kidney deficiency and Duhan syndrome JO - Acta Chinese Med VL - 34 ID - Chiwen2019 ER - TY - JOUR AU - Min, T. PY - 2011 DA - 2011// TI - Clinical observation on the treatment of 28 cases of oophoroma with Guizhifuling pills and adjuvant JO - Anti-tumor Pharm VL - 1 ID - Min2011 ER - TY - JOUR AU - Han, L. AU - Guo, X. AU - Bian, H. AU - Yang, L. AU - Chen, Z. AU - Zang, W. AU - Yang, J. PY - 2016 DA - 2016// TI - Guizhi Fuling wan, a traditional Chinese herbal formula, sensitizes Cisplatin-resistant human ovarian Cancer cells through inactivation of the PI3K/AKT/mTOR pathway JO - Evid Based Complement Alternat Med VL - 16 ID - Han2016 ER - TY - JOUR AU - Han, L. AU - Guo, X. J. AU - Chen, Z. AU - Bian, H. AU - Zhang, C. Y. AU - Zang, W. H. AU - Wang, Q. AU - Hu, J. L. PY - 2018 DA - 2018// TI - the mechanisms of paeonol reversing multidrug resistance in ovarian cancer SKOV3/DDP cells JO - Yao Xue Xue Bao VL - 53 ID - Han2018 ER - TY - BOOK PY - 2015 DA - 2015// TI - Pharmacopoeia of Peoples Republic of China PB - China medical Science and Technology Press CY - Beijing ID - ref38 ER - TY - JOUR AU - Hsin, K. Y. AU - Matsuoka, Y. AU - Asai, Y. AU - Kamiyoshi, K. AU - Watanabe, T. AU - Kawaoka, Y. AU - Kitano, H. PY - 2016 DA - 2016// TI - systemsDock: a web server for network pharmacology-based prediction and analysis JO - Nucleic Acids Res VL - 44 UR - https://doi.org/10.1093/nar/gkw335 DO - 10.1093/nar/gkw335 ID - Hsin2016 ER - TY - JOUR AU - Dinesh, P. AU - Rasool, M. PY - 2018 DA - 2018// TI - Berberine inhibits IL-21/IL-21R mediated inflammatory proliferation of fibroblast-like synoviocytes through the attenuation of PI3K/Akt signaling pathway and ameliorates IL-21 mediated osteoclastogenesis JO - Cytokine VL - 106 UR - https://doi.org/10.1016/j.cyto.2018.03.005 DO - 10.1016/j.cyto.2018.03.005 ID - Dinesh2018 ER - TY - JOUR AU - Ma, J. AU - Xie, S. L. AU - Geng, Y. J. AU - Jin, S. AU - Wang, G. Y. AU - Lv, G. Y. PY - 2014 DA - 2014// TI - In vitro regulation of hepatocellular carcinoma cell viability, apoptosis, invasion, and AEG-1 expression by LY294002 JO - Clin Res Hepatol Gastroenterol VL - 38 UR - https://doi.org/10.1016/j.clinre.2013.06.012 DO - 10.1016/j.clinre.2013.06.012 ID - Ma2014 ER - TY - JOUR AU - Han, L. AU - Guo, X. AU - Bian, H. AU - Zhou, Y. AU - Li, T. AU - Yang, J. PY - 2015 DA - 2015// TI - Changed expression and function of P-gp in peripheral blood CD56+ cells predicting chemoresistance in non-Hodgkin lymphoma patients JO - Cancer Biomark VL - 15 UR - https://doi.org/10.3233/CBM-150467 DO - 10.3233/CBM-150467 ID - Han2015 ER - TY - JOUR AU - Li, H. AU - Hua, B. AU - Jingfeng, O. AU - Yuefeng, B. AU - Lei, Y. AU - Songshan, Y. PY - 2016 DA - 2016// TI - Wenyang Huazhuo Tongluo formula, a Chinese herbal decoction, improves skin fibrosis by promoting apoptosis and inhibiting proliferation through down-regulation of survivin and cyclin D1 in systemic sclerosis JO - BMC Complement Altern Med VL - 16 UR - https://doi.org/10.1186/s12906-016-1056-6 DO - 10.1186/s12906-016-1056-6 ID - Li2016 ER - TY - JOUR AU - Cheng, Y. AU - Chu, Y. AU - Su, X. AU - Zhang, K. AU - Zhang, Y. AU - Wang, Z. AU - Xiao, W. AU - Zhao, L. AU - Chen, X. PY - 2018 DA - 2018// TI - Pharmacokinetic-pharmacodynamic modeling to study the anti-dysmenorrhea effect of Guizhi Fuling capsule on primary dysmenorrhea rats JO - Phytomed VL - 48 UR - https://doi.org/10.1016/j.phymed.2018.04.041 DO - 10.1016/j.phymed.2018.04.041 ID - Cheng2018 ER - TY - JOUR AU - Xiong, Z. AU - Lang, L. AU - Gao, X. AU - Xiao, W. AU - Wang, Z. AU - Zhao, L. PY - 2019 DA - 2019// TI - An integrative urinary metabolomic study of the therapeutic effect of Guizhi Fuling capsule on primary dysmenorrheal rats based 1H NMR and UPLC-MS JO - J Pharm Biomed Anal VL - 164 UR - https://doi.org/10.1016/j.jpba.2018.11.039 DO - 10.1016/j.jpba.2018.11.039 ID - Xiong2019 ER - TY - JOUR AU - Zhang, Y. PY - 2017 DA - 2017// TI - Systematic screening and characterization of multiple constituents in Guizhi Fuling capsule and metabolic profiling of bioactive components in rats using ultra-high-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry JO - J Chromatogr B Analyt Technol Biomed Life Sci VL - 1061-1062 UR - https://doi.org/10.1016/j.jchromb.2017.07.021 DO - 10.1016/j.jchromb.2017.07.021 ID - Zhang2017 ER - TY - JOUR AU - Zhao, L. AU - Xiong, Z. AU - Sui, Y. AU - Zhu, H. AU - Zhou, Z. AU - Wang, Z. AU - Zhao, Y. AU - Xiao, W. AU - Lin, J. AU - Bi, K. PY - 2015 DA - 2015// TI - Simultaneous determination of six bioactive constituents of Guizhi Fuling capsule in rat plasma by UHPLC-MS/MS: application to a pharmacokinetic study JO - J Chromatogr B Analyt Technol Biomed Life Sci VL - 1001 UR - https://doi.org/10.1016/j.jchromb.2015.07.031 DO - 10.1016/j.jchromb.2015.07.031 ID - Zhao2015 ER - TY - JOUR AU - Shen, S. M. PY - 2018 DA - 2018// TI - Nuclear PTEN safeguards pre-mRNA splicing to link Golgi apparatus for its tumor suppressive role JO - Nat Commun VL - 9 UR - https://doi.org/10.1038/s41467-018-04760-1 DO - 10.1038/s41467-018-04760-1 ID - Shen2018 ER - TY - JOUR AU - Davis, A. AU - Tinker, A. V. AU - Friedlander, M. PY - 2014 DA - 2014// TI - "platinum resistant" ovarian cancer: what is it, who to treat and how to measure benefit JO - Gynecol Oncol VL - 133 UR - https://doi.org/10.1016/j.ygyno.2014.02.038 DO - 10.1016/j.ygyno.2014.02.038 ID - Davis2014 ER - TY - JOUR AU - Pylväs-Eerola, M. AU - Liakka, A. AU - Puistola, U. AU - Koivunen, J. AU - Karihtala, P. PY - 2016 DA - 2016// TI - Cancer stem cell properties as factors predictive of Chemoresistance in Neoadjuvantly-treated patients with ovarian Cancer JO - Anticancer Res VL - 36 ID - Pylväs-Eerola2016 ER - TY - JOUR AU - Davidson, B. AU - Holth, A. AU - Hellesylt, E. AU - Tan, T. Z. AU - Huang, R. Y. AU - Tropé, C. AU - Nesland, J. M. AU - Thiery, J. P. PY - 2015 DA - 2015// TI - The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions JO - Hum Pathol VL - 46 UR - https://doi.org/10.1016/j.humpath.2014.10.004 DO - 10.1016/j.humpath.2014.10.004 ID - Davidson2015 ER - TY - JOUR AU - Freimund, A. E. AU - Beach, J. A. AU - Christie, E. L. AU - Bowtell, D. PY - 2018 DA - 2018// TI - Mechanisms of drug resistance in high-grade serous ovarian Cancer JO - Hematol Oncol Clin North Am VL - 32 UR - https://doi.org/10.1016/j.hoc.2018.07.007 DO - 10.1016/j.hoc.2018.07.007 ID - Freimund2018 ER - TY - JOUR AU - Thakur, B. AU - Ray, P. PY - 2017 DA - 2017// TI - Cisplatin triggers cancer stem cell enrichment in platinum-resistant cells through NF-κB-TNFα-PIK3CA loop JO - J Exp Clin Cancer Res VL - 36 UR - https://doi.org/10.1186/s13046-017-0636-8 DO - 10.1186/s13046-017-0636-8 ID - Thakur2017 ER - TY - JOUR AU - Chekerov, R. PY - 2018 DA - 2018// TI - Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial JO - Lancet Oncol VL - 19 UR - https://doi.org/10.1016/S1470-2045(18)30372-3 DO - 10.1016/S1470-2045(18)30372-3 ID - Chekerov2018 ER - TY - JOUR AU - Tsou, S. H. AU - Hou, M. H. AU - Hsu, L. C. AU - Chen, T. M. AU - Chen, Y. H. PY - 2016 DA - 2016// TI - Gain-of-function p53 mutant with 21-bp deletion confers susceptibility to multidrug resistance in MCF-7 cells JO - Int J Mol Med VL - 37 UR - https://doi.org/10.3892/ijmm.2015.2406 DO - 10.3892/ijmm.2015.2406 ID - Tsou2016 ER - TY - JOUR AU - Xu, J. AU - Liu, D. AU - Niu, H. AU - Zhu, G. AU - Xu, Y. AU - Ye, D. AU - Li, J. AU - Zhang, Q. PY - 2017 DA - 2017// TI - Resveratrol reverses doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer JO - J Exp Clin Cancer Res VL - 36 UR - https://doi.org/10.1186/s13046-016-0487-8 DO - 10.1186/s13046-016-0487-8 ID - Xu2017 ER - TY - JOUR AU - Li, W. AU - Zhai, L. AU - Zhao, C. AU - Lv, S. PY - 2015 DA - 2015// TI - MiR-153 inhibits epithelial-mesenchymal transition by targeting metadherin in human breast cancer JO - Breast Cancer Res Treat VL - 150 UR - https://doi.org/10.1007/s10549-015-3346-y DO - 10.1007/s10549-015-3346-y ID - Li2015 ER - TY - JOUR AU - Guo, C. C. AU - Zheng, L. H. AU - Fu, J. Y. AU - Zhu, J. H. AU - Zhou, Y. X. AU - Zeng, T. AU - Zhou, Z. K. PY - 2015 DA - 2015// TI - Antiosteoporotic effects of Huangqi Sanxian decoction in cultured rat osteoblasts by proteomic characterization of the target and mechanism JO - Evid Based Complement Alternat Med VL - 2015 ID - Guo2015 ER - TY - JOUR AU - Anantharaju, P. G. AU - Gowda, P. C. AU - Vimalambike, M. G. AU - Madhunapantula, S. V. PY - 2016 DA - 2016// TI - An overview on the role of dietary phenolics for the treatment of cancers JO - Nutr J VL - 15 UR - https://doi.org/10.1186/s12937-016-0217-2 DO - 10.1186/s12937-016-0217-2 ID - Anantharaju2016 ER - TY - JOUR AU - Rajasekaran, D. PY - 2015 DA - 2015// TI - Combination of nanoparticle-delivered siRNA for astrocyte elevated Gene-1 (AEG-1) and all-trans retinoic acid (ATRA): an effective therapeutic strategy for hepatocellular carcinoma (HCC) JO - Bioconjug Chem VL - 26 UR - https://doi.org/10.1021/acs.bioconjchem.5b00254 DO - 10.1021/acs.bioconjchem.5b00254 ID - Rajasekaran2015 ER - TY - JOUR AU - Bild, A. H. PY - 2006 DA - 2006// TI - Oncogenic pathway signatures in human cancers as a guide to targeted therapies JO - Nat VL - 439 UR - https://doi.org/10.1038/nature04296 DO - 10.1038/nature04296 ID - Bild2006 ER - TY - JOUR AU - Vizeacoumar, F. J. PY - 2013 DA - 2013// TI - A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities JO - Mol Syst Biol VL - 1 UR - https://doi.org/10.1038/msb.2013.54 DO - 10.1038/msb.2013.54 ID - Vizeacoumar2013 ER - TY - JOUR AU - Havugimana, P. C. PY - 2012 DA - 2012// TI - A census of human soluble protein complexes JO - Cell VL - 150 UR - https://doi.org/10.1016/j.cell.2012.08.011 DO - 10.1016/j.cell.2012.08.011 ID - Havugimana2012 ER - TY - JOUR AU - Burington, B. AU - Barlogie, B. AU - Zhan, F. AU - Crowley, J. AU - Shaughnessy, J. D. PY - 2008 DA - 2008// TI - Tumor cell gene expression changes following short-term in vivo exposure to single agent chemotherapeutics are related to survival in multiple myeloma JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-07-4568 DO - 10.1158/1078-0432.CCR-07-4568 ID - Burington2008 ER - TY - JOUR AU - Oughtred, R. PY - 2019 DA - 2019// TI - The BioGRID interaction database: 2019 update JO - Nucleic Acids Res VL - 47 UR - https://doi.org/10.1093/nar/gky1079 DO - 10.1093/nar/gky1079 ID - Oughtred2019 ER - TY - JOUR AU - George, S. PY - 2017 DA - 2017// TI - Loss of PTEN is associated with resistance to anti-PD-1 checkpoint blockade therapy in metastatic uterine Leiomyosarcoma JO - Immun VL - 46 UR - https://doi.org/10.1016/j.immuni.2017.02.001 DO - 10.1016/j.immuni.2017.02.001 ID - George2017 ER - TY - JOUR AU - Dhiman, G. AU - Lohia, N. AU - Jain, S. AU - Baranwal, M. PY - 2016 DA - 2016// TI - Metadherin peptides containing CD4(+) and CD8(+) T cell epitopes as a therapeutic vaccine candidate against cancer JO - Microbiol Immunol VL - 60 UR - https://doi.org/10.1111/1348-0421.12436 DO - 10.1111/1348-0421.12436 ID - Dhiman2016 ER -